EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis

Hui Zheng, Yan Chen, Yunsheng Xu, Xinjie Deng

European Journal of Dermatology · 2023

DOI: 10.1684/ejd.2023.4557 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Dermatology, 2023. Verfasst von Hui Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Eczema. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicEczemaAdultHumansAdolescentPyrimidinesSulfonamidesTreatment OutcomeSeverity of Illness IndexDouble-Blind Method

Stichwörter der Autor:innen

abrocitinibatopic dermatitiseczema JAK inhibitorsmeta-analysissystematic review

Substanzen

abrocitinibPyrimidinesSulfonamides

Autor:innen und Institutionen

  • Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China.
  • Department of Dermatology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, 324000, Quzhou, China.
  • Department of Dermatology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, 324000, Quzhou, China, Department of Dermatovenereology, The Seventh Affiliated Hospital, Sun Yat-sen Un…

Zitieren

APA

Zheng, H., Chen, Y., Xu, Y., & Deng, X. (2023). Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis. European Journal of Dermatology. https://doi.org/10.1684/ejd.2023.4557

Vancouver

Zheng H, Chen Y, Xu Y, Deng X. Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis. European Journal of Dermatology. 2023. doi:10.1684/ejd.2023.4557

BibTeX
@article{Zheng2023,
  author = {Zheng, Hui and Chen, Yan and Xu, Yunsheng and Deng, Xinjie},
  title = {Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis},
  journal = {European Journal of Dermatology},
  year = {2023},
  doi = {10.1684/ejd.2023.4557}
}
Kostenlos starten →